GlaxoSmithKline yanks Paxil batches after FDA warning letter | PharmaBoardroom

GlaxoSmithKline yanks Paxil batches after FDA warning letter

face
TAGS: ,

GlaxoSmithKline has its second recall in as many weeks on its hands, this time affecting batches of the antidepressant Paxil that contain an ingredient manufactured at an Irish plant the FDA says isn't up to snuff.

Latest Report